Skip to main content
Premium Trial:

Request an Annual Quote

Purely Proteins, Abcam to Develop Proteome-Wide Set of Protein/Antibody Pairs

NEW YORK, Feb. 17 (GemomeWeb News) - Purely Proteins and Abcam today announced a collaborative agreement under which the firms will jointly identify and produce a set of protein-antibody pairs that spans the entire human proteome.

Under the collaboration, the companies said they will produce families of therapeutically relevant proteins and protein domains together with their corresponding antibodies. The companies will use Purely Proteins' TargetBase protein database to gather information about known members of specific protein families, while Abcam will design and produce specific antibodies to these targets.

The companies will jointly market protein/antibody combinations developed as part of the collaboration.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.